Globus Medical ‘top pick’ among spine names at NASS, says Piper Jaffray

Piper Jaffray analyst Matt O’Brien kept his Overweight rating and $58 price target on Globus Medical as part of his broader research note on the companies participating in the North American Spine Society, or NASS, Annual Meeting, saying it is his “top pick”. The analyst says its Excelsius robotic system sales should go higher and possibly above expectations given the “very strong interest” shown by the practitioners at the meeting, adding that the management has been “surprised” by the pullthrough of its sales efforts into “competitive accounts”.
https://thefly.com/landingPageNews.php?id=2796821